Track the ZEVRA THERAPEUTICS, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €687.1m. The latest transaction was filed on 17 August 2026 (Cession). Among the most active insiders: Watton Corey Michael. Every trade is free.
51
Insider Decl.
n/a
Thresholds
€644,601
26 ops.
Buy Volume
€1m
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ZEVRA THERAPEUTICS, INC. Strong Buy (bullish), based on 9 analysts. Average price target: US$25.00.
59Σ signal
Buys €644,601€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,401 of 29,064 companies
79.1
score / 100
Value
68
Quality
91
FCF yld-0.3%
Earn yld12%
EV/EBITDA7.7x
ROE35%
Gross mgn85%
Net mgn78%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.